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SummAry
The aim of the study consists in a systematic review concerning the economic evaluation of cochlear implant (Ci) in children by searching 
the main international clinical and economic electronic databases. All primary studies published in English from January 2000 to may 2010 
were included. The types of studies selected concerned partial economic evaluation, including direct and indirect costs of cochlear im-
plantation; complete economic evaluation, including minimization of costs, cost-effectiveness analysis (CEA), cost-utility analysis (CuA) 
and cost-benefit analysis (CBA) performed through observational and experimental studies. A total of 68 articles were obtained from 
the database research. of these, 54 did not meet the inclusion criteria and were eliminated. After reading the abstracts of the 14 articles 
selected, 11 were considered eligible. The articles were then read in full text. Furthermore, 5 articles identified by bibliography research 
were added manually. After reading 16 of the selected articles, 9 were included in the review. With regard to the studies included, countries 
examined, objectives, study design, methodology, prospect of analysis adopted, temporal horizon, the cost categories analyzed strongly 
differ from one study to another. Cost analysis, cost-effectiveness analysis and an analysis of educational costs associated with cochlear 
implants were performed. regarding the cost analysis, only two articles reported both direct cost and indirect costs. The direct cost ranged 
between € 39,507 and € 68,235 (2011 values). The studies related to cost-effectiveness analysis were not easily comparable: one study 
reported a cost per QAly ranging between $ 5197 and $ 9209; another referred a cost of $ 2154 for QAly if benefits were not discounted, 
and $ 16,546 if discounted. Educational costs are significant, and increase with the level of hearing loss and type of school attended. This 
systematic review shows that the healthcare costs are high, but savings in terms of indirect and quality of life costs are also significant. 
Cochlear implantation in a paediatric age is cost-effective. The exiguity and heterogeneity of studies did not allow detailed comparative 
analysis of the studies included in the review.
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riASSunTo
L’obiettivo dello studio consiste nella revisione sistematica della letteratura scientifica avente come oggetto la valutazione economica degli 
impianti cocleari nei bambini. La revisione sistematica è stata condotta compiendo una ricerca nelle principali banche dati internazionali 
in ambito clinico ed economico. Sono stati inclusi tutti gli studi primari pubblicati in inglese dal gennaio 2000 al maggio 2010. Le tipologie 
di studio incluse sono le seguenti: analisi di valutazione economica parziale, quale analisi dei costi diretti e indiretti dell’impianto cocle-
are; analisi di valutazione economica completa, quali analisi di minimizzazione dei costi, analisi di costo efficacia (ACE), analisi di costo 
utilità (ACU) e analisi di costo beneficio (ACB) effettuate attraverso studi osservazionali e studi sperimentali. Dalla ricerca nelle banche 
dati sono risultati 68 articoli. Di questi, 54 non incontrano i criteri di inclusione quindi sono stati eliminati. Dopo la lettura degli abstract 
dei 14 articoli selezionati, ne sono stati inclusi 11, ritenuti eleggibili. Si è proceduto, dunque, alla lettura degli articoli in full text copy. 
Sono stati, inoltre, identificati dalla ricerca nelle bibliografie 5 articoli che sono stati aggiunti manualmente. Dopo la lettura dei 16 articoli 
selezionati, ne sono stati inclusi 9. I paesi studiati, gli obiettivi, il disegno dello studio, la metodologia, la prospettiva di analisi adottata, 
l’orizzonte temporale, le categorie di costo analizzate differiscono molto da studio a studio. Nella revisione è stata effettuata un’analisi dei 
costi, della costo-efficacia e dei costi educativi. Rispetto all’analisi dei costi, soltanto due articoli riportano sia i costi diretti che indiretti. 
I costi diretti variano tra € 39,507 e € 68,235 (€ 2011). Gli studi relativi all’analisi di costo-efficacia non sono facilmente comparabili: 
uno studio riporta un costo per QALY che oscilla tra $ 5,197 e $ 9,209; un altro autore riferisce un costo di $ 2,154 per QALY se i benefici 
non sono scontati e di $ 16,546 se i benefici sono scontati. I costi educativi sono significativi, aumentano con il livello di perdita di udito 
e il tipo di scuola frequentata. La revisione sistematica mostra che i costi sanitari sono più alti ma i risparmi in termini di costi indiretti e 
di qualità di vita sono significativi. L’impianto cocleare, dunque, nell’età pediatrica è costo-efficace. L’esiguità e l’eterogeneità degli studi 
non permette di condurre un’analisi comparativa degli studi inclusi nella review. 
pArolE ChiAvE: Perdita di udito • Impianto cocleare • Analisi dei costi • Costo-efficacia • Costo educativo
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Introduction and aim
A systematic review of the literature was performed to 
summarize the results of studies on the economic evalua-
tion of cochlear implants in paediatric patients.
Method
This systematic review of the literature was conducted 
with explicit and reproducible methodology to minimize 
any possible distortions, biases or erroneous conclusions 
due to the lack of inclusion of important studies, accord-
ing to the criteria of The Cochrane Collaboration and oth-
ers 1 2.
Research strategy
The systematic review of the literature was performed 
in September 2009 and updated on 31 may 2010, inter-
rogating international electronic databases both in the 
clinical and economic sectors: “pubmed mEdlinE” 
and  the  “Centre  for  reviews  and  dissemination”, 
which  includes  the  Economic  Evaluation  database 
(nhS EEd), the database of Abstracts of reviews of 
Effects (dArE) and the health Technology Assessment 
(hTA) database. The search was made using keywords, 
Boolean operators and mesh descriptor. The results ob-
tained from database query were imported by refWorks 
version 6.0, a software for the management of biblio-
graphic data that allows removal of duplicate records. 
After having identified the publications, two reviewers, 
working independently, reviewed the titles and the ab-
stracts, applying the below-described inclusion and ex-
clusion criteria. Any differing opinions were resolved 
by discussion.
Criteria of study selection
Inclusion criteria
All primary studies published in English from 2000 up 
to the moment of the search were eligible for inclusion 
(may 2010).
Types of studies
•  partial economic evaluation, including direct, indirect 
and quality of life costs of cochlear implantation;
•  complete economic evaluation, including minimization 
of costs, cost-effectiveness, cost-utility and cost-bene-
fit evaluation performed through observational and ex-
perimental studies.
Outcomes
in particular, we considered the following outcomes:
•  efficacy unit cost measured in physical units through 
the incremental cost-effectiveness ratio (iCEr);
•  cost of quality adjusted life years (QALY);
•  benefit unit cost measured in monetary units;
•  direct and indirect costs of cochlear implantation.
The articles presenting the costs of the years before 2000 
were also included in the review.
Exclusion criteria
Studies not meeting the inclusion criteria were excluded, 
and in particular unreviewed conference papers, system-
atic reviews, case reports, letters and commentaries were 
not included. non-English studies published before 2000 
were not considered.
The selected studies were considered eligible as well as 
articles  selected  through  the  consultation  of  bibliogra-
phies of publications, either pertinent or recommended by 
professionals engaged in this field, and responding to the 
inclusion criteria defined, in order to minimize any possi-
ble distortions, biases, or erroneous conclusions due to the 
lack of inclusion of important studies on the issue. After 
identification, two reviewers, working independently, re-
viewed the titles and the abstracts, applying the eligibility 
criteria previously defined. Eligible studies were carefully 
examined in full text, assessing coherence, consistency 
and methodological quality, using the available tools to 
evaluate both internal and external validity, including the 
criteria of Evers 3.
Results
A total of 68 articles were obtained from the database re-
search. of these, 54 did not meet the inclusion criteria and 
were eliminated. After reading the abstracts of the remain-
ing 14 articles, 11 were considered eligible. The articles 
were then read in full text. Furthermore, 5 articles identi-
fied by bibliography research were added manually. After 
reading these 16 articles, 9 were included in the review.
Following is a list of the 7 articles excluded, along with 
the reasons for exclusion.
o’neill et al. 4, as the method used for assessment of the 
costs was not clear.
Sach et al. 5, because the article deals with cost-effective-
ness, although the costs are only briefly mentioned and 
not reported exhaustively.
Copeland et al. 6, as it was too generic, and does not per-
form a cost analysis.
Taylor et al. 7, because it was not sufficiently clear with 
regard to the content in the article. An economic evalua-
tion was undertaken, but the Authors only report on other 
cost-effectiveness studies (which in any case are treated 
too superficially). The costs for cochlear implants are not 
provided, and only an estimate of the potential needs is 
performed, reporting the aggregate costs for children and 
adults.
manrique  et  al. 8,  due  to  the  absence  of  a  method  for 
identification of the healthcare resources consumed and 
valorization of cost units. The authors mention cochlear Economic evaluation of cochlear implants in paediatric patients
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implantation costs in the abstract only, and do not deal 
with the problem in the main text. definition of the target 
population, follow-up and study design are unclear.
Smith-olinde et al. 9, as the authors did not perform an 
analysis of costs, but only describe the quality of life of 
children with permanent hearing impairment.
raine et al. 10, since it is focused only on the absence of 
use of the cochlear implant, and therefore the reported 
costs only concern non-usage of the device, while the aim 
of the present review is to assess cost-effectiveness of im-
plantation.
With regard to the studies included, countries examined, 
objectives, study design, methodology, prospect of analy-
sis adopted and temporal horizon, the cost categories ana-
lyzed strongly differ from one another.
We performed an analysis of costs, a cost-effectiveness 
analysis and an educational cost analysis associated with 
cochlear implants. The following is a summary of some of 
the features of the studies included:
•  7 studies were conducted in Europe (5 in Great Britain 
4,12,17-19, 1 in germany  15 and 1 in France  11), 1 in the 
united States 13 and 1 in Canada 16; 
•  2 multicentre studies 11 12, 3 single-centre studies 13 5 6;
•  3 prospective studies 11-13, 3 retrospective studies 14-16, 3 
cross-sectional studies 17-19.
The studies had different objectives:
Cheng 13 aimed to determine the quality of life and cost 
of cochlear implantation in children with hearing impair-
ment. o’neill 14 investigated the cost-utility of cochlear 
implants, and includes cost savings associated with edu-
cation. Schulze-gattermann 15 analyzed, from the point of 
view of the payer, the cost-benefits of cochlear implan-
tation in children with congenital deafness and perilin-
gual deafness, comparing them with children using hear-
ing aids. Barton 12 evaluated the costs of 12 programmes 
adopted for Ci in the uK, using the micro-costing meth-
od.  Barton  17  has  two  objectives:  the  former  consisted 
in evaluating out-of-pocket expenses by the families of 
hearing-impaired children; the latter attempted to verify 
the types of differences when assessment is performed 
from a societal point of view. Barton 18 assessed the cost-
effectiveness of cochlear implants from a societal point of 
view. Barton 19 aimed to evaluate the impact on costs on 
the education of hearing-impaired children. Fitzpatrick 16 
aimed to identify direct and indirect Ci costs, and at de-
fining the benefits for children with prelingual deafness. 
molinier 11 evaluated the direct medical costs of Ci from 
the payer’s point of view.
The 9 articles included in the review used different meth-
ods for assessment of the economic impact of cochlear 
implantation in children.
Cheng 13 and o’neill 14 conducted a cost-utility study as 
well as an evaluation of Ci costs. Cheng 13 reported the di-
rect and indirect costs of cochlear implantation; o’neill 14 
analyzed the total direct costs and educational costs for 
paediatric  patients.  Schulze-gattermann  15  performed  a 
cost-benefit study relative to the evaluation of direct and 
indirect healthcare costs of cochlear implant vs. hearing 
aid. Furthermore, the author analyzed the costs relative 
to nursery and primary Schools. Barton 12 estimated the 
average cost of Ci and the impact of the total cost on the 
English healthcare System. Barton 17 studied out-of-pock-
et expenses made by families of a sample of children with 
and without cochlear implantation.
The study by Barton 18 analyzed the cost-effectiveness of 
cochlear implantation from the point of view of Ci social 
costs and “health utility”. Barton 19 evaluated Ci impact 
in terms of average cost per child according to the type 
of school and average yearly costs for the education of 
implanted children and children with different levels of 
hearing loss. using a retrospective study, Fitzpatrick 16 re-
ported on the direct healthcare costs for Ci children. mo-
linier 11 analyzed direct healthcare costs in a multicentre 
prospective study.
The article by Schulze-gattermann 15 is the only one that 
compared a group of cochlear implanted children vs. a 
group of children with hearing aid. The other studies do 
not perform any such comparison. in some cases, com-
parisons are performed between samples of children who 
use cochlear implant vs. children who do not.
The articles selected by Barton et al. 17-19 refer to the study 
by Fortnum 20 who consider children born from 1980 to 
1995, residing in the uK in 1998, with severe permanent 
hearing loss for a total of 17,600 children.
Seven  articles  take  into  account  a  sample  of  patients, 
while the other 2 refer to the costs of Ci programs 12 14. 
molinier 11 is the only author who considered both adult 
and paediatric patients in the same study.
The utilities analyzed were different according to the ge-
neric tool employed: time-trade-off (TTo), visual ana-
logue scale (vAS), health utilities index-mark iii (hui) 13, 
hui-3  18  a. Applied  discount  rate:  none  11  16,  3%  13  18  19, 
6% 12 14 5.
Cost analysis
The studies performing an analysis of direct and indirect 
costs are Cheng 13 and Schulze-gattermann 15. o’neill 14, 
Barton 12, Fitzpatrick 16 and molinier 11 only performed an 
analysis of the direct costs.
According to Cheng 13, the direct costs for the use of co-
chlear implants relative to 1999 are $ 60,228, while in-
direct costs are $113,426. Thus, Ci implies cost savings 
of $ 53,198 per child. The direct costs are estimated us-
ing the medicare resource-Based relative-value Scale 
(rBrvS) with regard to health benefits provided during 
the pre-operative, operative and post-operative stages. The 
a An explanation of these quality of life assessment instruments is provided in the paragraph relative to cost-effectiveness.g. Turchetti et al.
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costs for the device, guarantee and batteries are estimated 
as the mean costs of the most commonly used implants.
indirect costs include lost working hours and changes in 
the fields of education and income. lost working hours in 
families were calculated considering 4 hours per visit and 
average income calculated according to type of work and 
sex. Three working days of leave were considered at the 
time of the intervention. Changes in the costs of education 
are based on differences in educational placements before 
and after receiving the implant.
Schulze-gattermann 15 analyzed direct and indirect costs 
in four groups of patients (group 1: Ci before 1 year and 
9 months with congenital and prelingual deafness; group 
2: Ci from 2 to 3 years and 9 months with prelingual or 
perilingual deafness; group 3: Ci from 4 to 6 years and 9 
months with prelingual or perilingual deafness; group 4: 
children with hearing aid). The total costs for the three 
groups of children using Ci varied from € 138,000 to 
€ 177,000 vs. € 160,000 for prosthesis users.
direct  and  indirect  discounted  healthcare  costs  were 
€ 57,000 for group 1, € 52,000 for group 2, and € 46,000 
for group 3. healthcare costs for children using prostheses 
were € 18,000. The author reported the aggregate costs, 
and therefore it is impossible to assess direct and indirect 
costs separately.
o’neill 14 evaluated the direct costs of cochlear implants 
obtained from the nottingham paediatric Cochlear im-
plant programme. The total cost after the first 4 years was 
$ 60,480 and was distributed as follows: the assessment 
and implant costs were $ 44,000 (first year), rehabilitation 
and maintenance $ 6,400 (second and third year), mainte-
nance $ 3,680.
Barton 12 defined the average costs relative to the different 
stages of the implant which were: € 3,743 for assessment, 
€ 27,863 for implantation, € 12,044 for mapping, € 6,209 
for the first year of maintenance and € 2,497 for the fol-
lowing years, € 6,569 for updating of the sound processor 
(every 10 years). The average cost, discounted at 1 year, 
was € 42,972, after 15 years was € 73,763 and € 95,034 
after 73 years.
in the period 2000/2001, the total cost from the perspec-
tive of the healthcare System for Ci in 237 children map-
ping or maintenance in 1290 previously implanted chil-
dren was estimated to be € 14.2 million. Average lifelong 
healthcare costs for implantation and maintenance of an 
implanted child in the uK were estimated to be € 95,000.
Fitzpatrick 16 estimated the average direct healthcare costs 
for each child at $ 64,171.46 (Canadian dollars), and dis-
tributed as follows: 4.8% for assessment, 44.5% for hard-
ware, 2.8% for surgery, 5.4% for hospitalization, 0.1% 
for post-surgery follow up; follow-up at 1st year absorbs 
19.8%, follow-up at 2nd year 12.8% and follow-up at 3rd 
year accounting for 10.3% of costs.
molinier 11 analyzed direct healthcare costs in a multi-
centre prospective study conducted on 268 children in 19 
French university hospitals. The average cost per child 
was € 34,686, of which 64.4% is represented by device 
costs. Costs were distributed as follows: € 814 for pre-op-
erative assessment (65.7% of costs for tests and outpatient 
visits, 34.3% for hospitalization), € 24,498 for implanta-
tion (8.8% for hospitalization and 91.2% for the device), 
€ 6,743 for rehabilitation (88.5% for tests and outpatient 
visits, 11.5% for hospitalization) and € 2,631 for travel 
expenses.
Table i shows a comparison relative to the direct costs 
reported by the selected authors. The costs were first in-
flated to the year 2011 and then converted in Euros in case 
of different currencies. in order to inflate until the year 
2011, the Consumer price index and the gross domestic 
product deflator index for the euro zone were used for the 
dollar and euro, respectively. Conversions from the uSA 
dollar to euro ($1 ± € 0.70) were performed up to 14 June 
2011.
From the table, it can be seen that the direct costs range 
between € 39,507 11 and € 68,235 12. The device represents 
Table I. Direct costs of cochlear implants in children (Euro, 2011).
Cheng 13 € 56,611 total direct costs
• 4.8% pre-operative costs
• 40.6% operative costs
• 54.6% post-operative costs 
O’Neill 14 € 58,104 total direct costs (after the first 4 years)
• 72.7% evaluation and implant
• 21.2% rehabilitation and maintenance
• 6.1% maintenance
Barton 12 € 68,235 average total direct costs
• 6.5% evaluation
• 48.8% implant
• 21.1% mapping
• 10.9% first year of maintenance
• 8.4% second year of maintenance
• 4.4% following years
Fitzpatrick 16 € 53,197 total direct healthcare costs
• 4.8% evaluation
• 52.3% implant
• 19.8% post-implant follow-up (1st year)
• 12.8% post-implant follow-up (2nd year)
• 10.3% post-implant follow-up (3rd year)
Molinier 11 € 39,507 average direct healthcare costs
• 2.4% pre-operative costs
• 70.6% implant
• 19.4% rehabilitation
• 7.6% travel
Note: Schulze-Gattermann 15 was not included in the review as aggregate direct 
and indirect costs were reported.Economic evaluation of cochlear implants in paediatric patients
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one of the most significant costs: 32% of the total direct 
costs in Cheng 13, 72.7% of the total (estimate-associat-
ed cost) in o’neill 14, 48.8% in Barton 12, 52.3% in Fitz-
patrick 16 and 70.6% in molinier 11. The percentage rela-
tive to post-operative costs was 54.6% of the total costs 
in Cheng 13, 42.9% in Fitzpatrick 16, 27.3% in o’neill 14, 
23.7% in Barton 12 and 19.4% in molinier 11.
Cost-effectiveness assessment
The  articles  assessing  cost-effectiveness  are  Cheng  13, 
o’neill 14 and Barton 18. Cheng 13 evaluates the cost-utility 
of cochlear implantation from a social perspective using 
three different quality of life assessment instruments: vis-
ual analogue scale (vAS), time trade off (TTo) and health 
utility index (hui). The vAS consists in a scale ranging 
from 0 (death) to 1 (perfect health) in which respondents 
indicate a number corresponding to their perception of the 
quality of life. in TTo, the respondents have two alterna-
tives: alternative 1 is the current state of health for time t 
(remaining life expectancy); alternative 2 corresponds to 
an excellent state of health for time x. hui is a question-
naire organized according to the following health sectors: 
hearing,  language,  sight,  feeling,  pain,  deambulation, 
cognition and personal care.
The mean score reported by vAS respondents reaches 0.27 
(along a 0-1 scale) passing from 0.59 before surgery to 0.86 
after implantation. The mean score of TTo ranges from 0.75 
(immediately before implantation) to 0.97 after implantation, 
with an increase of 0.22. The hui score ranges from 0.25 
before surgery to 0.64 after implantation, with an increase of 
0.39. direct health costs for QAly are $ 9,029 using TTo, 
$ 7,500 using the vAS and $ 5,197 using the hui.
Considering  cost-utility,  o’neill  14  reported  a  cost  of 
$ 2,154 for QAly if benefits were not discounted and 
$ 16,546 if benefits were discounted. The author claimed 
that if we consider a child implanted at the age of 4 with 
a life expectancy of 74 years, the QAly costs gained are 
16.33.
Barton 18 demonstrated increased health saving costs in 
children with worse pre-implantation hearing loss, when 
relating pre-operative hearing loss and an age at 3 and 6 
years at the time of the implant. higher QAly cost sav-
ings were associated with worse hearing loss, younger 
age at time of implantation and longer duration of implant 
usage. Barton performed an analysis of the QAly costs 
according to the different prospects: social, sanitary, ag-
gregate sanitary and education costs. health/QAly costs 
relative to life duration were estimated to vary between 
€ 15,410 (for a child implanted at 3 years, with pre-op-
erative hearing loss of 125 dB) and € 47,723 (for a child 
implanted at 6 years with hearing loss of 105 dB). in con-
clusion, cost-effectiveness is more favourable when life 
duration is estimated instead of 15-year-age, for children 
with worse level of hearing loss and for children implant-
ed at a younger age.
Analysis of education costs
o’neill 14 compared the costs of education in a child with 
hearing loss between 70 and 95 dB and a child with hear-
ing loss of 95 dB. The costs refer to the 4th year of educa-
tion (an 8-year-old child at primary school) and 7th year 
of  education  (an  11-year  3-month  old  child  at  middle 
school).
Schulze-gattermann 15 claimed that education costs cov-
ered by the public healthcare system depend on the dif-
ferent types of schools. in the base scenario, the costs for 
deaf children’s nursery schools are € 28,820 per year vs. 
€ 7,810 for traditional schools. primary schools for deaf 
children cost € 16,410 per year vs. € 4,450 for traditional 
schools.  Furthermore,  education  costs  are  higher  than 
healthcare costs. in the uK, education is compulsory from 
the age of 4 to 16: primary school goes from 4 to 11 years 
and middle school from 11 to 16 years. in group 1 (0-1.9 
years), 58.7% of total costs are represented by education 
costs and 41.3% by healthcare costs, in group 2 (2-3.9 
years) 69.4% is absorbed by education costs and 30.6% 
by healthcare costs, in group 3 (4-6.9 years) 74% and 26% 
are education and healthcare costs, respectively, and in 
group 4 (children using hearing aids) 88.7% of costs are 
related to education costs and 11.3% to medical costs.
Barton  19  distributed  the  sample  according  to  the  level 
of hearing loss (moderate, severe, profound 96-105 dB, 
Table II. Educational costs for children (Euro, 2011).
O’Neill 14 Yearly average costs
Hearing loss of 95 dB
- child at 4th yr of education: € 15,507
- child at 7th yr of education: € 18,852
Hearing loss 70-95 dB
- child at 4th yr of education: € 11,931
- child at 7th yr of education: € 12,114
Schulze-
Gattermann 15
Discounted aggregate educational costs
- Group 1 (CI before 21 mths): € 100,521
- Group 2 (CI between 2 yrs and 3 yrs 9 
mths): € 146,438
- Group 3 (CI between 4 yrs and 6 yrs 9 
mths): € 162,571
- Group 4 (children with acoustic prosthesis): 
€ 176,222
Barton 19 Yearly total educational costs
- Children with moderate AHL: € 18,338
- Children with severe AHL: € 26,155
- Children with profound AHL (96-105 dB): 
€ 31,776
- Children with profound AHL (> 105 dB): 
€ 37,910
- Children with implant: € 32,331g. Turchetti et al.
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profound > 105 dB and implanted) and of type of school 
attended. The annual costs for education varied between 
€ 15,745 in the group with moderate hearing loss and 
€ 28,059 for implanted children.
Table ii shows the educational costs reported by o’neill 14, 
Schulze-gattermann 15 and Barton 19, which were first in-
flated to 2011 and then converted to Euro as described 
in the paragraph “Cost analysis”. Conversions from uSA 
dollars to Euro ($ 1 = € 0.70) were performed up to 14 
June 2011.
Discussion
The articles examined concern the economic aspects 
of  cochlear  implantation  according  to  different  ap-
proaches: direct and indirect cost analysis, and educa-
tional and cost-effectiveness analysis. Cheng 13 is the 
only author who reported the direct and indirect costs 
in detail, clearly specifying the methodology employed 
for their estimation. Costs are referred to the lifetime 
of an implanted child. Furthermore, the author con-
ducted a cost-utility analysis with three different utility 
instruments, stating that cochlear implantation is cost-
effective, and generates important health benefits and 
cost-savings for society. direct healthcare costs vary 
from $ 5,197 to $ 9,027 for QAly using the three in-
struments. Schulze-gattermann 15 deals with direct and 
indirect, but not aggregate costs, and reports the total 
costs for the three implanted groups of children com-
pared to the group using cochlear implant. The author 
reaches the conclusion that cochlear implantation im-
plies a cost-benefit relation that is favourable to im-
plantation vs. prosthesis. Educational costs are much 
higher than healthcare and indirect costs, and increase 
with the age of the implant.
The article by o’neill 14 took into account cochlear im-
plantation funding based on full costs, including compli-
cations and maintenance with reference to the Ci program 
of the uK. Education costs and cost-utility were also de-
scribed. The analysis of all types of costs is however too 
superficial and is unclear.
Barton 12 clearly defined the methodology employed for 
cost assessment, measuring the resources associated with 
Ci (staff, accommodation, equipment, accessory expenses, 
hospitalization, device implantation and adverse events), 
using the micro-costing method b. The level of use of each 
resource is reported up to the financial year 1998/1999 
and all costs are inflated to 2000/2001.
mean costs for each implanted child, aggregate expenses 
for the different phases of the pathway included processor 
improvement, healthcare costs, and total yearly costs of 
the healthcare system. Fitzpatrick 16 examined direct and 
indirect costs; however, the latter are only quoted, but not 
evaluated. direct costs, related to a retrospective analy-
sis of 18 Ci children, were referred to the period from 
pre-implantation assessment to 3 years after implantation. 
The author quotes the education costs and those incurred 
by the family, but does not quantify them in monetary 
terms.
molinier 11 performed a prospective assessment only of 
the direct costs of Ci in France, but the investigation could 
trigger further cost-effectiveness and cost-utility studies. 
The economic analysis takes into account all the phases 
of the patient’s pathway with Ci, but stops at 1-year of 
follow up.
The three studies 13 14 8 perform a cost-effectiveness analy-
sis, but are not easily comparable between themselves; in 
particular, the analysis made by o’neill 14 is not as ac-
curate as the ones performed by Cheng 13 and Barton 18. 
Cheng 13 performs a cost-utility analysis according to type 
of instrument employed, reporting cost per QAly which 
ranges between $ 5,197 and $ 9,209. o’neill 14 reports 
cost per QAly which vary from $ 2,153 when the costs 
are not discounted, to $ 16,546 when the discount is ap-
plied, concluding that Ci is a cost-effective in children 
with profound hearing-impairment.
Barton 18 carried out an in-depth cost-effectiveness analy-
sis and showed that health utility costs are significant and 
broad enough to justify costs. Furthermore, he retained 
that the benefits are greater in children with higher pre-
operative hearing loss and in younger children.
in this review, it was decided to also include education 
costs, which are very significant from an economic point 
of  view,  as  demonstrated  by  the  authors  selected. The 
costs increase with the level of hearing loss and type of 
schools attended.
in the analysis by Schulze-gattermann 15, the percentages 
of children attending traditional schools varied from 69% 
in the groups of children implanted before 1 year and 9 
months to 12% in the group of children using a hearing 
aid. The costs both of nursery schools (€ 28,820) and 
primary schools (€ 16,410) for hearing-impaired chil-
dren are very high compared to the traditional schools 
(€ 7,810 and € 4,450, respectively). The author claims 
that the differences in education settings between groups 
of children of different ages are supported by several 
studies showing that hearing, language, and education 
skills are better in children receiving implantation when 
they are younger.
A  drawback  we  found  in  present  review  is  the  small 
number of studies that have been published since 2000, 
making  comparisons  difficult.  Furthermore,  the  studies 
performing an estimate of costs are exclusively concen-
trated on the direct costs; only Cheng 13 made an in-depth 
analysis of indirect costs. however, it was possible to pro-
vide an economic picture of the impact of Ci.
b The micro costing method, according to which a cost unit is assigned for each resource, is used to estimate the total costs.Economic evaluation of cochlear implants in paediatric patients
317
it was not possible to compare the different types of im-
plants (monolateral vs. bilateral, bilateral sequential vs. 
monolateral implantation), and the implants in children 
with associated disabilities and hearing aid, as they are 
not reported by the authors included in the review. The 
comparisons we found concerned children with cochlear 
implantation vs. children with acoustic prosthesis 15, im-
planted vs. non-implanted children 17-19.
no quantitative synthesis of the results using a meta-anal-
ysis was feasible, as the data emerging from the articles 
could not be compared, owing to different factors, includ-
ing scarce number of studies and differences in terms of 
country, sample, study design, follow-up, utility measures 
and cost items.
The outcomes of the various studies could not be pooled 
due to inherent differences as a result of above features. 
Since meta-analysis is necessary when the same treatment 
is assessed in a considerable number of studies, in this 
case meta-analysis of only a few heterogeneous studies 
would lead to results that would be unreliable and difficult 
to reproduce.
Conclusion
Cochlear implant represents a significant surgical innova-
tion, and is the first artificial organ of sense able to evoke 
acoustic feelings by stimulating the inner ear. Ci in chil-
dren represents a controversial issue from an economic, 
clinical and ethical point of view. The ethical problem 
derives from the fact that Ci implies a permanent lesion 
of the receptor and total loss of the residual ear, although 
it is possible to maintain partial or total hearing in some 
cases.
A number of studies show that the benefits are superior 
to the risks, and demonstrate an improvement in the qual-
ity of life of implanted children. Ci has increased con-
siderably over time, even in children aged ≤ 12 months 
as the introduction and diffusion of screening have led to 
a considerable reduction in the mean age at diagnosis of 
congenital hearing loss.
A congenitally hearing-impaired child identified at birth, 
with hearing aids in the first 6 months and implanted with-
in two years of age, may be able to attend nursery school 
with no need for educational support 21.
Schulze-gattermann 15 claims that, from the payer’s point 
of  view,  implantation  for  prelingual  hearing-impaired 
children is strongly recommended for children receiving 
an implant before two years of age, which involves saving 
costs of 13% compared to youngsters using the prosthesis 
until the age of 16 years. Another critical aspect is repre-
sented by high costs, as emerges from the studies included 
in the review, with particular regard to the costs of the 
device. if on the one hand the healthcare costs are high, 
the savings in terms of indirect costs and quality of life are 
considerable. Furthermore, as we have seen, the elevated 
school costs have decreased, especially in the countries in 
which special schools for hearing impaired children are 
present.
From the clinical studies, it also emerged that there has 
been an improvement in communication benefits, support-
ing the hypotheses of those who claim that early interven-
tion ensures optimal results. The impact of Ci is positive 
for the life of the child both from social and educational 
point of views.
Therefore, unilateral Ci in a paediatric age is cost-effec-
tive. on the basis of the present review, no studies have 
examined cost-effectiveness of bilateral Ci in a paediat-
ric age. A number of recent international reviews on Ci 22 
confirm that simultaneous bilateral Ci procedure is cost-
effective in paediatric patients.
The exiguity and heterogeneity of investigations did not 
allow  detailed  comparative  analysis  of  the  studies  in-
cluded. Therefore, it was necessary to perform an analysis 
based on three different approaches: cost analysis, cost-
effectiveness analysis and analysis of educational costs, 
which allowed a small cross-section to be obtained con-
cerning the economic impact on cochlear impacts in pae-
diatric patients. it is necessary both to consider the high 
healthcare and education costs, and to make an assess-
ment in terms of benefits for children with Ci.
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